Thiol signalling network with an eye to diabetes

Molecules

Volumn 15, Issue 12, 2010, Pages 8890-8903

  Matteucci, Elena ^a   Giampietro, Ottavio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Arterial hypertension; Diabetes mellitus; N acetylcysteine; Oxidation reduction; Sulphydryl compounds

Indexed keywords

REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HOMEOSTASIS; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HOMEOSTASIS; HUMANS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SULFHYDRYL COMPOUNDS;

EID: 78650675859     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15128890     Document Type: Article

References (59)

1. Ingenbleek, Y. The nutritional relationship linking sulfur to nitrogen in living organisms. J. Nutr. 2006, 136, 1641S-1651S.
2. Joint WHO/FAO/UNU Expert Consultation. Protein and amino acid requirements in human nutrition. World Health Organ. Tech. Rep. Ser. 2007, 935, 1-265.
3. van de Poll, M.C.G.; Dejong, C.H.C.; Soeters, P.B. Adequate range for sulfur-containing amino acids and biomarkers for their excess: lessons from enteral and parenteral nutrition. J. Nutr. 2006, 136, 1694S-1700S.
4. Schafer, F.Q.; Buettner, G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001, 30, 1191-1212.
5. Jacob, C.; Anwar, A. The chemistry behind redox regulation with a focus on sulphur redox systems. Physiol. Plant. 2008, 133, 469-480.
6. Go, Y.M.; Jones, D.P. Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 2008, 1780, 1273-1290.
7. Ye, H.; Rouault, T.A. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 2010, 49, 4945-4956.
8. Netto, L.E.; de Oliveira, M.A.; Monteiro, G.; Demasi, A.P.; Cussiol, J.R.; Discola, K.F.; Demasi, M.; Silva, G.M.; Alves, S.V.; Faria, V.G.; Horta, B.B. Reactive cysteine in proteins: protein folding, antioxidant defense, redox signaling and more. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2007, 146, 180-193.
9. Hansen, R.E.; Østergaard, H.; Winther, J.R. Increasing the reactivity of an artificial dithioldisulfide pair through modification of the electrostatic milieu. Biochemistry 2005, 44, 5899-5906.
10. Wouters, M.A.; George, R.A.; Haworth, N.L. "Forbidden" disulfides: their role as redox switches. Curr. Protein Pept. Sci. 2007, 8, 484-495.
11. Berndt, C.; Lillig, C.H.; Holmgren, A. Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim. Biophys. Acta 2008, 1783, 641-650.
12. Finn, R.D.; Mistry, J.; Tate, J.; Coggill, P.C.; Heger, A.; Pollington, J.E.; Gavin, O.L.; Gunasekaran, P.; Ceric, G.; Forslund, K.; Holm, L.; Sonnhammer, E.L.; Eddy, S.R.; Bateman, A. The Pfam protein families database. Nucleic. Acids Res. 2010, 38, D211-D222.
13. Holmgren, A.; Lu, J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem. Biophys. Res. Commun. 2010, 396, 120-124.
14. Herrero, E.; de la Torre-Ruiz, M.A. Monothiol glutaredoxins: a common domain for multiple functions. Cell. Mol. Life Sci. 2007, 64, 1518-1530.
15. Shelton, M.D.; Kern, T.S.; Mieyal, J.J. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy. J. Biol. Chem. 2008, 282, 12467-12474.
16. Appenzeller-Herzog, C.; Ellgaard, L. The human PDI family: versatility packed into a single fold. Biochim. Biophys. Acta 2008, 1783, 535-548.
17. Nardai, G.; Stadler, K.; Papp, E.; Korcsmáros, T.; Jakus, J.; Csermely, P. Diabetic changes in the redox status of the microsomal protein folding machinery. Biochem. Biophys. Res. Commun. 2005, 334, 787-795.
18. Tessari, P.; Puricelli, L.; Iori, E.; Arrigoni, G.; Vedovato, M.; James, P.; Coracina, A.; Millioni, R. Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy. J. Proteome Res. 2007, 6, 976-986.
19. Dalle-Donne, I.; Rossi, R.; Colombo, G.; Giustarini, D.; Milzani, A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem. Sci. 2009, 34, 85-96.
20. Sampathkumar, R.; Balasubramanyam, M.; Sudarslal, S.; Rema, M.; Mohan, V.; Balaram, P. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin. Biochem. 2005, 38, 892-899.
21. Mueller, A.S.; Bosse, A.C.; Most, E.; Klomann, S.D.; Schneider, S.; Pallauf, J. Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats. J. Nutr. Biochem. 2009, 20, 235-247.
22. Abbas, K.; Breton, J.; Drapier, J.C. The interplay between nitric oxide and peroxiredoxins. Immunobiology 2008, 213, 815-822.
23. Chen, L.; Na, R.; Salmon, A.B.; Liu, Y.; Liang, H.; Qi, W.; Van Remmen, H.; Richardson, A.; Ran, Q. Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 2008, 7, 866-878.
24. Carvalho-Filho, M.A.; Ueno, M.; Hirabara, S.M.; Seabra, A.B.; Carvalheira, J.B.; de Oliveira, M.G.; Velloso, L.A.; Curi, R.; Saad, M.J. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 2005, 54, 959-967.
25. Wu, G.; Fang, Y.Z.; Yang, S.; Lupton, J.R.; Turner, N.D. Glutathione metabolism and its implications for health. J. Nutr. 2004, 134, 489-492.
26. Blanco, R.A.; Ziegler, T.R.; Carlson, B.A.; Cheng, P.Y.; Park, Y.; Cotsonis, G.A.; Accardi, C.J.; Jones, D.P. Diurnal variation in glutathione and cysteine redox states in human plasma. Am. J. Clin. Nutr. 2007, 86, 1016-1023.
27. Qiao, M.; Zhao, Q.; Lee, C.F.; Tannock, L.R.; Smart, E.J.; LeBaron, R.G.; Phelix, C.F.; Rangel, Y.; Asmis, R. Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 1779-1786.
28. Matteucci, E.; Giampietro, O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care 2000, 23, 1182-1186.
29. Matteucci, E.; Malvaldi, G.; Fagnani, F.; Evangelista, I.; Giampietro, O. Redox status and immune function in type I diabetes families. Clin. Exp. Immunol. 2004, 136, 549-554.
30. Simic, D.V.; Mimic-Oka, J.; Pljesa-Ercegovac, M.; Savic-Radojevic, A.; Opacic, M.; Matic, D.; Ianovic, B.; Simic, T. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J. Hum. Hypertens. 2006, 20, 149-155.
31. Matteucci, E.; Rosada, J.; Pinelli, M.; Giusti, C.; Giampietro, O. Systolic blood pressure response to exercise in type 1 diabetes families compared with healthy control individuals. J. Hypertens. 2006, 24, 1745-1751.
32. Ashfaq, S.; Abramson, J.L.; Jones, D.P.; Rhodes, S.D.; Weintraub, W.S.; Hooper, W.C.; Vaccarino, V.; Alexander, R.W.; Harrison, D.G.; Quyyumi, A.A. Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension 2008, 52, 80-85.
33. Lash, L.H. Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem. Biol. Interact. 2006, 163, 54-67.
34. Nakamura, H. Extracellular functions of thioredoxin. Novartis Found. Symp. 2008, 291, 184-192.
35. Bloomfield, K.L.; Osborne, S.A.; Kennedy, D.D.; Clarke, F.M.; Tonissen, K.F. Thioredoxinmediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter. Gene 2003, 319, 107-116.
36. Aon, M.A.; Cortassa, S.; Maack, C.; O'Rourke, B. Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J. Biol. Chem. 2007, 282, 21889-21900.
37. Hansen, J.M.; Watson, W.H.; Jones, D.P. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. 2004, 82, 308-317.
38. MacLeod, A.K.; McMahon, M.; Plummer, S.M.; Higgins, L.G.; Penning, T.M.; Igarashi, K.; Hayes, J.D. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 2009, 30, 1571-1580.
39. Foster, M.W.; Hess, D.T.; Stamler, J.S. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol. Med. 2009, 15, 391-404.
40. Gaston, B.; Singel, D.; Doctor, A.; Stamler, J.S. S-nitrosothiol signaling in respiratory biology. Am. J. Respir. Crit. Care Med. 2006, 173, 1186-1193.
41. Allen, B.W.; Stamler, J.S.; Piantadosi, C.A. Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation. Trends Mol. Med. 2009, 15, 452-430.
42. Münzel, T.; Sinning, C.; Post, F.; Warnholtz, A.; Schulz, E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann. Med. 2008, 40, 180-196.
43. Cersosimo, E.; DeFronzo, R.A. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab. Res. Rev. 2006, 22, 423-436.
44. Galkina, E.; Ley, K. Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 2009, 27, 165-197.
45. Zou, M.H.; Shi, C.; Cohen, R.A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 2002, 109, 817-826.
46. Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54, 1615-1625.
47. Stabler, T.; Kenjale, A.; Ham, K.; Jelesoff, N.; Allen, J. Potential mechanisms for reduced delivery of nitric oxide to peripheral tissues in diabetes mellitus. Ann. NY Acad. Sci. 2010, 1203, 101-106.
48. Palmer, L.A. Regulation of respiration and endothelial gene expression by S-nitrosothiols in health and disease. Proc. Am. Thorac. Soc. 2006, 3, 166-169.
49. Hildebrandt, W.; Alexander, S.; Bärtsch, P.; Dröge, W. Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity. Blood 2002, 99, 1552-1555.
50. Palmer, L.A.; Doctor, A.; Chhabra, P.; Sheram, M.L.; Laubach, V.E.; Karlinsey, M.Z.; Forbes, M.S.; Macdonald, T.; Gaston, B. S-nitrosothiols signal hypoxia-mimetic vascular pathology. J. Clin. Invest. 2007, 117, 2592-2601.
51. Rahangdale, S.; Yeh, S.Y.; Malhotra, A.; Veves, A. Therapeutic interventions and oxidative stress in diabetes. Front. Biosci. 2009, 14, 192-209.
52. Yilmaz, H.; Sahin, S.; Sayar, N.; Tangurek, B.; Yilmaz, M.; Nurkalem, Z.; Onturk, E.; Cakmak, N.; Bolca, O. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. Acta Cardiol. 2007, 62, 579-585.
53. Miner, S.E.; Cole, D.E.; Evrovski, J.; Forrest, Q.; Hutchinson, S.J.; Holmes, K.; Ross, H.J. Nacetylcysteine neither lowers plasma homocysteine concentrations nor improves brachial artery endothelial function in cardiac transplant recipients. Can. J. Cardiol. 2002, 18, 503-507.
54. Martina, V.; Masha, A.; Ramella Gigliardi, V.; Brocato, L.; Manzato, E.; Berchio, A.; Massarenti, P.; Settanni, F.; Della Casa, L.; Bergamini, S.; Iannone, A. Long-term N-acetylcysteine and Larginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 2008, 31, 940-944.
55. Pendyala, L.; Creaven, P.J. Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial. Cancer Epidemiol. Biomarkers Perv. 1995, 4, 245-251.
56. Moschou, M.; Kosmidis, E.K.; Kaloyianni, M.; Geronikaki, A.; Dabarakis, N.; Theophilidis, G. In vitro assessment of the neurotoxic and neuroprotective effects of N-acetyl-L-cysteine (NAC) on the rat sciatic nerve fibers. Toxicol. In Vitro 2008, 22, 267-274.
57. Masha, A.; Brocato, L.; Dinatale, S.; Mascia, C.; Biasi, F.; Martina, V. N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus. J. Endocrinol. Invest. 2009, 32, 352-356.
58. Wouters, M.A.; Fan, S.W.; Haworth, N.L. Disulfides as redox switches: from molecular mechanisms to functional significance. Antioxid. Redox Signal. 2010, 12, 53-91.
59. Xu, J.; Zou, M.H. Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 2009, 120, 1266-1286.